Organized colorectal cancer screening programmes: How to optimize efficiency in the general population

European Journal of Cancer Prevention

Volumn 20, Issue SUPPL. 1, 2011, Pages

  Calazel Benque, Anne ^a   Viguier, Jérôme ^b   Roussel, Claire ^c   Pivot, Xavier ^d,e   Eisinger, François ^f,g   Blay, Jean Yves ^h,i   Coscas, Yvan ^j   Morère, Jean François ^k,l  

^a Capio Clinique du Parc   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c Roche SAS   (France)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^e INSERM   (France)

^f INSTITUT PAOLI CALMETTES   (France)

^g AIX MARSEILLE UNIV   (France)

^h Leon Berard Cancer Center   (France)

ⁱ CENTRE LÉON BÉRARD   (France)

^j Porte de St Cloud Clinic   (France)

^k AVICENNE HOSPITAL   (France)

^l UNIVERSITÉ PARIS EST CRÉTEIL   (France)

more..

Author keywords

colonoscopy; colorectal cancer; faecal occult blood test; general population; screening

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CANCER SCREENING; COLORECTAL CANCER; FEMALE; GENERAL PRACTITIONER; HUMAN; MALE; PATIENT REFERRAL; POPULATION; PRIORITY JOURNAL;

EID: 79551543199     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000391566.41383.61     Document Type: Article

References (14)

1. Canard JM, Heresbach D (2010). La coloscopie en France en 2008: résultats de l'enquěte de deux jours d'endoscopie en France. Colonoscopy in France in 2008: results of the two-day survey of endoscopy in France. Acta Endoscopica 40:58-65.
2. Center for Disease Control and Prevention (CDC) (2006). Increased use of colorectal cancer tests: United States, 2002 and 2004. MMWR Morb Mortal Wkly Rep 55:308-311.
3. Deville JC (1991). A theory of quota surveys. Survey Methodology 17:163-181.
4. Eisinger F, Blay JY, Morère JF, Rixe O, Calazel Benqué A, Cals L, et al. (2008a). Cancer screening in France: subjects' and physicians' attitudes. Cancer Causes Control 19:431-434.
5. Eisinger F, Cals L, Calazel Benqué A, Blay JY, Coscas Y, Dolbeault S, et al. (2008b). Impact of organized programmes on colorectal cancer screening. BMC Cancer 8:104.
6. Finney Rutten LJ, Nelson DE, Meissner HI (2004). Examination of populationwide trends in barriers to cancer screening from a diffusion of innovation perspective (1987-2000). Prev Med 38:258-268.
7. Goulard H, Ancelle-Park R, Julien M, Bloch J (2006). Le cancer colorectal en France. Evaluation 2002 à 2004. Colorectal cancer in France. 2002 to 2004 evaluation. Institut de veille sanitaire, Saint-Maurice. Janvier, 6p.
8. Journal Officiel. no 295 du 21 décembre 2006, page 19240, texte no 49.
9. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondegaard O (1996). Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet 348:1467-1471.
10. Lejeune C, Arveux P, Dancourt V, Béjean S (2004). Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer. Int J Technol Assess Health Care 20:434-439.
11. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. (1993). Reducing mortality for colorectal cancer by screening for fecal occult blood. N Engl J Med 328:1365-1371.
12. Micksche M, Lynge E, Diehl V, Estape J, Vertio H, Faivre J, et al. (2001). Recommandations pour le dépistage du cancer dans l'Union Européenne [Recommendations on cancer screening in the European Union]. Bull Cancer 88:687-692.
13. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN (2002). Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intem Med 137:132-141.
14. Ransohoff DF (2005). Colon cancer screening in 2005: status and challenges. Gastroenterology 128:1685-1695.